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Abstract
Objective To report trends in event and case fatality rates for acute
myocardial infarction and examine the relative contributions of changes
in these rates to changes in total mortality from acute myocardial
infarction by sex, age, and geographical region between 2002 and 2010.
Design Population based study using person linked routine hospital and
mortality data.
Setting England.
Participants 840 175 people of all ages who were admitted to hospital
for acute myocardial infarction or died suddenly from acute myocardial
infarction.
Main outcome measures Acute myocardial infarction event, 30 day
case fatality, and total mortality rates.
Results From 2002 to 2010 in England, the age standardised total
mortality rate fell by about half, whereas the age standardised event and
case fatality rates both declined by about one third. In men, the acute
myocardial infarction event, case fatality, and total mortality rates declined
at an average annual rate of, respectively, 4.8% (95% confidence interval
3.0% to 6.5%), 3.6% (3.4% to 3.7%), and 8.6% (5.4% to 11.6%). In
women, the corresponding figures were 4.5% (1.7% to 7.1%), 4.2%
(4.0% to 4.3%), and 9.1% (4.5% to 13.6%). Overall, the relative
contributions of the reductions in event and case fatality rates to the
decline in acute myocardial infarction mortality rate were, respectively,
57% and 43% in men and 52% and 48% in women; however, the relative
contributions differed by age, sex, and geographical region.
Conclusions Just over half of the decline in deaths from acute
myocardial infarction during the 2000s in England can be attributed to
a decline in event rate and just less than half to improved survival at 30
days. Both prevention of acute myocardial infarction and acute medical
treatment have contributed to the decline in deaths from acute myocardial
infarction over the past decade.
Introduction
Declineshavebeenobservedinpopulationbasedmortalityrates
from coronary heart disease and acute myocardial infarction in
manydevelopedcountries,includingEngland,sincethe1970s.
1 2
For any given condition, the mortality rate in a population is a
function of the event rate and case fatality rate. Several studies
have investigated the drivers of the decline in mortality from
coronary heart disease. The most notable is the World Health
Organization’s Multinational Monitoring of Trends and
Determinants in Cardiovascular Disease (MONICA) project,
which examined trends in mortality rates, event rate, and one
month case fatality in men and women aged 35-64 from 38
populations in 21 countries over 10 years, from 1985-7 to
1995-7. The MONICA study found that, between the mid-80s
andmid-90s,twothirdsofthedeclineinmortalityfromcoronary
heart disease in people aged less than 65 years could be
attributed to the decline in coronary event rate and one third to
the decline in case fatality.
Studies from the MONICA centres showed that the relative
contributions of event rate and case fatality to the decline in
mortality from coronary heart disease vary by region and
country. The MONICA populations in the United Kingdom
were Glasgow and Belfast—there was no English population.
The relative contributions of event rate and case fatality for
acutemyocardialinfarctiontotheobserveddeclineinmortality
from acute myocardial infarction have not been studied for
England. Routinely collected national hospital and mortality
data can be informative. However, data linkage is necessary to
undertake a systematic analysis of the occurrence of person
based disease from routine national statistics. Since 1998 it has
been possible to link routinely collected hospital and mortality
data for the entire population of England. Using such a linked
dataset,wereporttrendsineventrateandcasefatalityforacute
myocardialinfarctionandexaminetherelativecontributionsof
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RESEARCHchanges in these rates to changes in mortality from acute
myocardial infarction by sex and age between 2002 and 2010
in England.
Methods
We obtained data from two national datasets, hospital episode
statistics and mortality statistics, which were linked by the
Oxford record linkage team. The hospital episode statistics
datasetprovidesinformationonallpatientsadmittedtohospital
and whose care is covered by the English National Health
Service, a publicly funded healthcare system that serves all
residentsofEngland.TheOfficeforNationalStatisticscollects
the data on mortality, including all deaths in residents of
England, whether in hospital or not.
Study population
Residents of England were included in the study if they
experienced an acute myocardial infarction event between 1
January2002and31December2010.Suchaneventwasdefined
as either an emergency hospital admission with a primary
diagnosisofacutemyocardialinfarction(ICD-10codesI21-I22,
international classification of diseases, 10th revision) and a
length of stay of more than one day for someone discharged
alive, or a death with acute myocardial infarction coded as the
underlying cause of death on the death certificate (ICD-9 code
410 and ICD-10 codes I21-I22). We applied the one day
criterion for hospital stay to avoid counting suspected acute
myocardial infarctions in patients who were discharged home
when acute myocardial infarction was not confirmed (2.8% of
records). In agreement with the MONICA definition of a new
acute myocardial infarction, we assumed any hospital or death
records that occurred within 30 days of an admission for acute
myocardial infarction to relate to the same event. We excluded
recordswithinvaliddates,missingage,ormissingsexfromthe
analysis (<0.1% of records).
Acute myocardial infarction events were categorised as fatal or
non-fatal. We defined fatal acute myocardial infarctions as
sudden deaths from acute myocardial infarction or admission
to hospital for acute myocardial infarction events that had a
death record within 30 days of a hospital admission for acute
myocardialinfarction,irrespectiveofthecauseorplaceofdeath.
For the purpose of this study sudden deaths from acute
myocardial infarction were those deaths with acute myocardial
infarction coded as the underlying cause of death on the death
certificate and with no linked hospital admission for acute
myocardial infarction in the previous 30 days.
To study regional differences in England we used the
government office region classification, based on the borders
defined by the Office for National Statistics. We obtained the
code, derived from the postal code of residence, from hospital
and mortality records.
Statistical analyses
The event rate was defined as the annual rate of occurrence of
acute myocardial infarction. We defined total mortality rate as
the annual rate of occurrence of deaths with acute myocardial
infarction recorded as the underlying cause of death. Using the
mid-year population estimates published by the Office for
National Statistics we calculated event and mortality rates per
100 000 population of England by age group and sex. Rates
were directly age standardised to the European standard
population.Weestimatedthe95%confidenceintervalsassuming
that the observed number of events followed a Poisson
distribution.
Using the total number of acute myocardial infarctions as the
denominator and all fatal acute myocardial infarctions as the
numerator, we calculated the overall 30 day case fatality rate
in each year. We calculated the 30 day case fatality rate during
hospital stay using the total number of hospital admissions for
acute myocardial infarction as the denominator and the number
offatalitieswithin30daysinthepopulationadmittedtohospital
as the numerator. Case fatality rates were directly age
standardisedusingfiveyearagegroupsandtheagedistribution
of the nine year acute myocardial infarction event cohort as the
standard population.
For event and mortality rates we estimated the average annual
percentage changes using Poisson regression analysis with the
natural logarithm of the age standardised annual rate as a
dependentvariableandcalendaryearasanindependentvariable.
For case fatality, we estimated the average annual percentage
changes using generalised linear model with binomial
distribution and a log link function. We calculated the average
annualpercentagechangefromtheβcoefficientforthecalendar
year, using −100×[1−exp(β)] as an approximation.
The relative contribution of event and case fatality rates to the
decline in deaths from acute myocardial infarction was
calculated using the same method as in the MONICA study. In
essence, the average annual change in mortality rate is the sum
of the average annual changes in event and case fatality rates,
expressed as percentages. This is based on the formulas that
mortality rate (M)=event rate(E)×case fatality rate(C) in each
year, and that M’/M=E’/E+C’/C, where M’, E’, and C’ stand
for the average annual change for each rate in absolute terms.
Letting ΔM=(M’/M), ΔE=(E’/E), and ΔC=(C’/C)—that is,
expressingtheaverageannualchangeinpercentageterms,gives
ΔM=ΔE+ΔC.
All analyses were done using STATA version 11.
Results
Between1January2002and31December2010,861134acute
myocardial infarctions occurred in 840 175 people in England.
Table 1⇓ shows the characteristics of the acute myocardial
infarction events over the study period by sex. Of all acute
myocardial infarctions, 61% occurred in men, 36% were fatal,
and 73% occurred in people aged 65 years and over. Of the 311
419fatalevents,70%weresuddendeathsfromacutemyocardial
infarction.
Trends in event rate
From 2002 to 2010, the age standardised acute myocardial
infarction event rate per 100 000 population decreased in men
from 230 (95% confidence interval 228 to 232) to 154 (153 to
155) and in women from 95.4 (94.5 to 96.3) to 66.0 (65.3 to
66.7) (table 2⇓). Comparing 2002 with 2010, acute myocardial
infarctioneventratesfellby33%inmenandby31%inwomen.
A declining event rate was seen in all age groups and for both
sexes.Thegreatestratesofdeclineoccurredinmenandwomen
aged 65-74 and the lowest in men and women aged 30-54 and
85 and older. The age standardised average annual change in
men was −4.8% (95% confidence interval −6.5% to −3.0%)
and in women was −4.5% (−7.1% to −1.7%). Declines were
observed in age standardised rates for both hospital admissions
for acute myocardial infarction and sudden deaths from acute
myocardial infarction for both sexes (fig 1⇓).
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From 2002 to 2010, the age standardised case fatality for acute
myocardial infarction decreased in men from 42.0% (95%
confidenceinterval41.6%to42.4%)to32.1%(31.7%to32.6%)
and in women from 42.2% (41.7% to 42.7%) to 29.9% (29.4%
to 30.4%) (table 2). Comparing 2002 with 2010, case fatality
rates fell by 24% in men and by 29% in women. A declining
case fatality rate was seen in all age groups and for both sexes.
The rates of decline were broadly similar between age groups
in men and in women, with only slightly higher rates in middle
agedpeopleandslightlylowerratesinyoungerandolderpeople.
Theagestandardisedaverageannualchangeinmenwas−3.6%
(95% confidence interval −3.7% to −3.4%) and in women was
−4.2% (−4.3% to −4.0%).
Case fatality among patients admitted to hospital for acute
myocardialinfarctiondecreasedataslightlyfasterratethanthe
overall case fatality rate, which includes sudden deaths from
acute myocardial infarction. Figure 2⇓ illustrates the declines
in both admissions to hospital and overall case fatality rates for
men and women over the study period. Rates for admissions to
hospital were about half the overall rates in each year.
Comparing 2002 with 2010, case fatality rates for admissions
to hospital decreased by 34% in men, from 18.5% (95%
confidence interval 18.2% to 18.9%) to 12.2% (11.8% to
12.5%), and by 38% in women, from 20.0% (19.6% to 20.5%)
to 12.5% (12.1% to 12.9%). The age standardised average
annual change in men was −5.2 (95% confidence interval −5.5
to −4.9) and in women was −5.6 (−5.9 to −5.3).
Trends in mortality
From 2002 to 2010, the age standardised mortality rate from
acute myocardial infarction per 100 000 population decreased
inmenfrom78.7(95%confidenceinterval77.7to79.8)to39.2
(38.6 to 39.9) and in women from 37.3 (36.8 to 37.9) to 17.7
(17.4 to 18.1) (table 2). Comparing 2002 with 2010, mortality
rates fell by 50% in men and by 53% in women. A declining
mortality rate was seen in all age groups and for both sexes.
The greatest rates of decline occurred in men and women aged
65-74 and the lowest in those aged 30-54 and 85 and older. The
age standardised average annual change in men was −8.6%
(95%confidenceinterval−11.6%to−5.4%)andinwomenwas
−9.1% (−13.6% to −4.5%).
Determinants of mortality trends
In men, the relative contribution of reductions in event rate to
the decline in mortality was higher than the contribution of
reductions in case fatality in all age groups except for those
aged85andolder,forwhomthecontributionswereaboutequal
(table 2). In women, the change in event rate played a larger
part than the change in case fatality in those aged 65-84, but the
opposite was found in women aged less than 55 and 85 and
older.
Overallforallages,justoverhalfofthedeclineintotalmortality
could be attributed to a decline in event rate (57% in men, 52%
in women) and just less than half to a decline in case fatality
rate (43% in men, 48% in women). A similar pattern was
observed for those aged less than 75, with about half of the
decline in mortality being driven by a decline in acute
myocardial infarction event rate (57% in men, 50% in women)
and about half by a decline in case fatality rate (43% in men,
50% in women).
Figure3⇓illustratestherelativecontributionsofeventandcase
fatality rates to the change in acute myocardial infarction
mortality rate from 2002 to 2010 by government office region.
All three rates declined in all the regions over the study period.
The relative contributions of reductions in event rate and case
fatality to the decline in mortality differed by region and there
was no consistent geographical pattern. The event rate played
aslightlybiggerpartthancasefatalityinsixoutofnineregions,
accountingforjustoverhalfofthedeclineinmortality.Notably,
thereductionsincasefatalityexplainedtwothirdsofthedecline
in deaths from acute myocardial infarction in London. Detailed
examination of data showed that this was driven by either
temporary increases or plateaus in acute myocardial infarction
event rates between 2007 and 2009 in both sexes and in all age
groups.
Discussion
Thisstudyreportsonrecenttrendsinacutemyocardialinfarction
events, 30 day case fatality, and total mortality rates between
2002 and 2010 in England. The results show that all rates have
declined. In other words, compared with earlier years, fewer
acute myocardial infarctions occurred in the past decade, and
of those that did occur, fewer were fatal. Total age standardised
deaths from acute myocardial infarction decreased by about
half, whereas the age standardised event rate and case fatality
each declined by about one third. The relative contributions of
the reductions in both event rate and case fatality to the decline
indeathsfromacutemyocardialinfarctiondifferedbysex,age,
and geographical region, with changes in case fatality playing
a greater part in women and older people. Overall, the average
annual reductions were similar for event and case fatality rates,
indicating that they contributed about equally to the decline in
mortality.
Trends over time
We have shown that the decline in the acute myocardial
infarction event rate and one month case fatality in the United
Kingdom,observedinpreviousdecades,continuedintothe21st
century. We report declines for all ages, both sexes, and all
geographical regions. However, the magnitude of the declines
differed by age group, with the greatest annual reductions in
event rate, case fatality, and mortality occurring among middle
aged people.
The annual declines in event rate were not statistically
significant for men and women aged 30-54 and 85 and older,
which raises the possibility that there was no real improvement
in the rate of occurrence of acute myocardial infarction in these
agegroupsoverthepastdecadeinEngland.Foryoungerpeople,
the rising rates of obesity and diabetes may be potential
contributingfactorstoalevellingofeventrate.Forolderpeople,
the lack of decline could result from a shift in the first
presentation of disease from middle age to older age
10 16 17 or a
change in diagnostic criteria, which possibly led to more cases
ofacutemyocardialinfarctionbeingdiagnosedinthisagegroup.
We also found non-significant annual declines in deaths from
acute myocardial infarction in men and women aged 30-54
years. These findings support previous reports of a flattening
and a possible reversal in coronary heart disease mortality rates
in young adults towards the end of the century,
13 14 17 21 and
reinforce the importance of monitoring and managing risk
factors in this population.
Explaining the decline in deaths from acute
myocardial infarction
Our findings that the reductions in event rate contributed just
over half and case fatality just less than half to the observed
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RESEARCHdecline in acute myocardial infarction mortality contrast with
the results of the MONICA study, which reported that the
declineineventrateaccountedfortwothirdsofthetotaldecline
in mortality. However, the MONICA findings were based on
data from previous decades, did not include adults aged older
than 65, and did not cover England. Therefore the MONICA
results are unlikely to apply to more recent years, be
representative of whole populations, or be directly applicable
to England.
In our study, the relative contribution of event rate and case
fatalitydifferedbyage:changesintheeventrateplayedabigger
part in middle aged people, whereas changes in case fatality
played a slightly bigger part in young and very old people. This
can be explained by the fact that, while the average annual
changes between 2002 and 2010 in case fatality rate did not
differ substantially between age groups, the declines in event
rate did. Changes in the event rate were lowest, as well as
non-significant, in the 30-54 and 85 and older age groups. As
a result, the relative contribution of changes in case fatality
differedbyageandwashigherforyoungerandforolderpeople.
Wereport,similartoothers,
21 22thatmostfatalacutemyocardial
infarctions were sudden deaths. Others have found that about
half of those dying suddenly from coronary heart disease or
acute myocardial infarction already have a history of
symptomatic coronary heart disease.
21 23 24 It is reasonable to
assumethatourcohortalsoconsistedofpeoplewithandwithout
pre-existing coronary heart disease. At least some of them are
likely to have been taking preventive drugs or making lifestyle
changes, particularly with the implementation of the National
Service Framework for coronary heart disease from 2000
onwards. Therefore, both primary prevention and secondary
prevention would have contributed to the decline in the rate of
sudden deaths from acute myocardial infarction. In addition to
reducingratesofsuddendeath,coronarypreventioncanreduce
disease severity and therefore may contribute to the decline in
case fatality for those who survive long enough to receive
hospital care for acute myocardial infarction. Furthermore,
changes in fatal outcomes among people admitted to hospital
for acute myocardial infarction also reflect, at least in part, the
contributionofimprovementsinacutemedicaltreatmentduring
the study time period.
Our data did not include clinical information on risk factors,
comorbidities, disease history, or current and past drug
prescriptions for the population studied, and thus we could not
address the relative importance of specific elements of
prevention and treatment. One modelling study suggested that
between 1981 and 2000 in England and Wales, reductions in
main risk factors contributed 58% to the decline in deaths from
coronaryheartdisease,andmedicaltreatmentcontributed42%.
During our study period, national survey data for England
indicates that the prevalence of smoking, high blood pressure,
and high cholesterol levels decreased, while the prevalence of
obesity and diabetes increased. In addition, drug prescriptions
for the prevention and treatment of coronary heart disease have
risen, as has the use of percutaneous coronary intervention
procedures.
We observed regional variation in the determinants of decline
in deaths from acute myocardial infarction, with the relative
contribution of event rate ranging fromabout onethird toabout
two thirds, but being just over half in most regions. These
findings are in agreement with the regional variation found
withinandbetweencountriesintheMONICAstudy.Ourstudy
provides further evidence that the drivers behind declining
mortality rates differ geographically and that results specific to
one region cannot necessarily be applied to other regions. The
increase in acute myocardial infarction event rate in London
between 2007 and 2009 may be a result of the financial crisis
that peaked in 2008 and greatly affected the London financial
district.Asaresult,thereductionsincasefatalityaccountedfor
most of the decline in deaths from acute myocardial infarction
in that region during the 2000s.
It is important to note that we only examined deaths from acute
myocardial infarction, and not all coronary heart disease. We
did not attempt a similar analysis of determinants of trends in
deathsfromcoronaryheartdiseasebecausewecouldnotreliably
identify all new coronary heart disease events (other than acute
myocardial infarction) using just hospital and mortality data.
Extrapolation of results presented here to all coronary heart
diseaseshouldbemadewithcaution.Agestandardisedmortality
rates from causes of non-acute myocardial infarction coronary
heart disease in England declined less than acute myocardial
infarctionmortalityoverthestudyperiod(datanotshown).This
could be driven by the decreasing severity of coronary heart
disease in the population, with fewer people developing the
acute manifestation of the disease as an acute myocardial
infarction. However, the precise reasons behind these trends
merit further research but lie beyond the scope of this study.
Strengths and limitations of the study
The strengths of this study include the large size of the cohort,
population level representation, complete national coverage,
and recent statistics. To the best of our knowledge, this is the
first study to apply MONICA’s statistical approach to
administrative data to explain recent trends in decline in deaths
fromacutemyocardialinfarctiononanationallevel.Withwider
availability of record linkage, analysis similar to the one
presentedinthispaperisincreasinglypossibleinothercountries.
Themainlimitationwastherelianceontheaccuracyandvalidity
of routine data. However, a systematic review of studies
comparing routine hospital discharge statistics with medical
records carried out in England, Wales, and Scotland reported,
on average, high accuracy rates for coding. In addition, the
quality of hospital data varies by condition, and common
diagnoses such as acute myocardial infarction are less likely to
be subject to miscoding than rare ones.
28 29 Linked Scottish
morbidity record database and patient episode database for
Wales, equivalents of the English hospital episodes statistics,
were reported to have high accuracy rates for the diagnosis of
acute myocardial infarction.
15 30
Any acute myocardial infarction events that occurred while
under private hospital care were not captured by the hospital
episodes statistics and thus not included in this study; however,
these events are likely to represent a small proportion of all
acute myocardial infarctions in England. Some of the excluded
peoplewithhospitaladmissionsforacutemyocardialinfarction
withastayofonedayorlessorthosewithasecondarydiagnosis
of acute myocardial infarction could have been true instances
of acute myocardial infarction. Any silent acute myocardial
infarctions that did not result in a hospital admission or a death
recordcouldnotbecapturedbytheavailabledataandthuswere
not included in the study. Some deaths coded as non-acute
myocardial infarction coronary heart disease as the underlying
cause of death could have been cases of acute myocardial
infarction,but,asthiswasnotknowable,theywerenotincluded.
New diagnostic criteria for acute myocardial infarction, which
relyontheuseofmoresensitivebiochemicalmarkersofdamage
to myocardium (troponins) for detection of acute myocardial
infarction, were introduced in 2000 by the European Society of
Cardiology and the American College of Cardiology.
31 The
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RESEARCHintroduction of these new criteria could have influenced our
estimates of event rate, especially in the early 2000s, because
adaptation and integration of troponins into clinical practice
happened gradually over time. Studies have shown that this
change in criteria affects estimates of trends in hospital
admissions for acute myocardial infarction but not for case
fatality within 30 days of admission to hospital for acute
myocardial infarction.
18 19 32 33 We could not directly quantify
the effect of the change in diagnostic criteria for acute
myocardial infarction on trends in hospital admissions because
we did not have any of the clinical information used in making
the diagnosis of acute myocardial infarction. However, the fact
that we still observed a decline in event rate during the 2000s
despite the use of the new criteria during that time provides
evidence of a real and beneficial change in the occurrence of
acute myocardial infarction in the English population.
Conclusions
Our study reports trends in event, case fatality, and total
mortality rates for acute myocardial infarction over the past
decade in England. It also examines the relative contribution of
changes in event rate and case fatality to the observed decline
indeathsfromacutemyocardialinfarction.Mostfatalitiesfrom
acute myocardial infarction continue to be sudden deaths.
Overall, just over half of the decline in deaths from acute
myocardial infarction can be attributed to a reduction in event
rate and just less than half to improved survival at 30 days.
However, the drivers behind declining mortality rates differ by
sex, age, and geographical region. The results also highlight
groups,particularlyyoungandveryoldpeople,whoexperienced
the least improvement in the occurrence of and mortality from
acute myocardial infarction. Further research is required to
elucidate the roles of population risk factor profiles, primary
and secondary prevention, and acute medical treatment in the
observed declines in acute myocardial infarction event, case
fatality, and mortality rates.
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RESEARCHWhat is already known on this topic
Population based mortality rates from coronary heart disease and acute myocardial infarction have been declining in England and other
developed countries since the 1970s
The relative contributions of changes in event rate and case fatality to the decline in total acute myocardial infarction mortality vary by
country and are not known for England and many other countries
What this study adds
In England during 2002-10 the age standardised total mortality rate fell by about half and the age standardised event and case fatality
rates both declined by about one third
The determinants of the declining mortality rates differed by sex, age, and geographical region
Overall, just over half of the decline in acute myocardial infarction mortality rate can be attributed to a decline in event rate and just less
than half to a decline in case fatality
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RESEARCHTables
Table 1| Characteristics of acute myocardial infarction events by sex, 2002-10, England
Events in women Events in men
All events (n=861 134) Characteristics Fatal (n=136 139) All (n=337 662) Fatal (n=175 280) All (n=523 472)
45 733 (18) 247 256 48 539 (12) 396 731 643 987 Hospital admission
90 406 (100) 90 406 126 741 (100) 126 741 217 147 Sudden death
81.0 (10), 83 77.4 (12), 80 74.4 (12), 77 69.4 (14), 71 72.5 (14), 75 Mean (SD) age (years), median
Age group:
70 (22) 320 178 (18) 994 1314 0-29
2840 (16) 17 886 12 245 (15) 79 932 97 818 30-54
6273 (21) 30 109 22 219 (22) 101 842 131 951 55-64
19 777 (31) 64 189 41 274 (32) 128 823 193 012 65-74
51 777 (43) 120 723 64 098 (44) 145 339 266 062 75-84
55 401 (53) 104 434 35 266 (53) 66 542 170 976 ≥85
Year:
19 711 (47) 41 996 24 914 (38) 65 317 107 313 2002
19 089 (46) 41 874 23 707 (37) 63 938 105 812 2003
17 148 (42) 40 589 21 963 (35) 62 720 103 309 2004
16 125 (41) 39 056 20 394 (34) 59 725 98 781 2005
14 606 (39) 37 075 18 990 (33) 57 396 94 471 2006
13 742 (38) 35 797 17 716 (32) 56 200 91 997 2007
12 892 (36) 35 365 16 755 (31) 54 694 90 059 2008
11 757 (35) 33 729 15 861 (30) 53 411 87 140 2009
11 069 (34) 32 181 14 980 (30) 50 071 82 252 2010
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RESEARCHTable 2| Trends in event rate, 30 day case fatality, and mortality for acute myocardial infarction by sex and age, 2002-10, England
Contribution to
mortality
decline§
Mortality rate (per 100 000) Case fatality rate (%) Event rate (per 100 000)
Age
group
Estimated
annual
trend‡ (%)
Annual
trend
(%)
Overall
change
(%) 2010 2002
Annual
trend
(%)
Overall
change
(%) 2010 2002
Annual
trend
(%)
Overall
change†
(%) 2010 2002
Case
fatality
rate (%)
Event
rate (%)
Men:
45 55 −5.9 −5.7* −39 1.2 2.0 −2.7 −22 13.8 17.6 −3.2* −26 8.8 11.9 30-54
42 58 −7.6 −7.7* −49 5.8 11.2 −3.2 −43 14.2 25.0 −4.4 −32 31.7 46.8 55-64
38 62 −10.0 −10.1 −56 13.7 31.3 −3.8 −48 19.5 37.2 −6.2 −41 53.3 89.7 65-74
39 61 −9.5 −9.7 −54 34.7 76.0 −3.7 −44 28.0 50.4 −5.7 −37 102 161 75-84
51 49 −6.5 −7.0 −42 84.8 145 −3.3 −38 37.9 61.2 −3.2 −22 199 254 ≥85
43 57 −8.2 −8.6 −51 20.3 41.4 −3.5 −23 22.1 28.9 −4.7 −34 104 156 <75
43 57 −8.3 −8.6 −50 39.2 78.7 −3.6 −24 32.1 42.0 −4.8 −33 154 230 All ages
Women:
80 20 −6.1 −5.9* −41 0.3 0.5 −4.9 −34 13.3 20.1 −1.2* −12 2.1 2.4 30-54
50 50 −9.6 −9.3* −54 1.5 3.3 −4.8 −30 17.4 24.8 −4.8* −36 9.0 14.0 55-64
44 56 −11.8 −11.6 −62 5.5 14.3 −5.1 −32 25.3 37.2 −6.7 −42 23.7 40.8 65-74
47 53 −9.7 −9.9 −55 19.0 42.3 −4.5 −29 35.8 50.7 −5.2 −34 59.7 89.8 75-84
58 42 −6.3 −6.8 −41 57.4 97.0 −3.7 −26 45.7 61.5 −2.7 −16 139 167 ≥85
50 50 −10.0 −10.3 −58 6.3 14.9 −5.0 −32 19.9 29.2 −5.0 −34 34.1 51.7 <75
48 52 −8.7 −9.1 −53 17.7 37.3 −4.2 −29 29.9 42.2 −4.5 −31 66.0 95.4 All ages
*P>0.05.
†(1−[rate in 2010]/[ rate in 2002])×100.
‡Based on average annual trends in event rate and case fatality.
§(event or case fatality annual trend/estimated mortality trend)×100.
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RESEARCHFigures
Fig 1 Age standardised event rates of acute myocardial infarction by sex and type of event, 2002-10, England
Fig 2 Age standardised 30 day overall and case fatality rates for admissions to hospital (%) for acute myocardial infarction
by sex, 2002-10, England
Fig 3 Contribution of average annual trends in event rate and case fatality to average annual trend in mortality for acute
myocardial infarction by government office region, 2002-10, England
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